MSD Archives - Pharmaphorum

Merck claims a brace of head and neck cancer approvals

https://pharmaphorum.com/news/merck-claims-a-brace-of-head-and-neck-cancer-approvals/

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast cancer

https://pharmaphorum.com/news/az-and-msds-lynparza-gets-eu-nod-for-hard-to-treat-breast-cancer/

R&D round-up: Non-opioid painkiller space heats up

https://pharmaphorum.com/views-and-analysis/rd-roundup-non-opioid-painkiller-space-heats-up/

Breaking new ground in digital content delivery for pharma

https://pharmaphorum.com/sales-marketing/breaking-new-ground-in-digital-content-delivery-for-pharma/

Inspiring a new generation of women in pharma

https://pharmaphorum.com/views-and-analysis/inspiring-a-new-generation-of-women-in-pharma/

Keytruda cuts risk of death by 31% in esophageal cancer trial

https://pharmaphorum.com/news/keytruda-cuts-risk-of-death-by-31-in-esophageal-cancer-trial/

Biosimilars underused in rheumatoid arthritis on the NHS – experts

https://pharmaphorum.com/news/biosimilars-underused-rheumatoid-arthritis-nhs-experts/

FDA approves Merck’s Delstrigo and Pifeltro for HIV treatment

https://pharmaphorum.com/news/fda-approves-mercks-hiv-treatment/

Celltrion hopes to outdo inflammatory disease rivals with SC infliximab

https://pharmaphorum.com/news/celltrion-hopes-to-outdo-inflammatory-disease-rivals-with-sc-infliximab/

Search